NEW YORK STOCK EXCHANGE, INC. · LLY
-0.31% · -$3.60 · Vol 2.5M
Market closed · last close 4:00 PM ET · price as of 19:41:14 ET
Eli Lilly and Co
Pharmaceuticals
$1,172.5
Veridion Score
BETAHIGH CONF · 6/6 factorsFri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET · LLY
MethodologyLLY
Eli Lilly and Co
Fri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET
BUY BIAS
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
63/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 28 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is LLY moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Eli Lilly and Co
PHARMACEUTICAL PREPARATIONSListed since
1970
Employees
50K
Country
US
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$1,172.66
Day high
$1,180
Day low
$1,162.93
Previous close
$1,176.1
52W high
$1,280.34
-8.42% from high
52W low
$714.59
81% of range
Market cap
$1T
P/E
49.89×
EPS
$23.50
Beta
-0.23
Shares out
891.4M
Volume
2.5M
0.93× rel vol
Avg volume
2.6M
VWAP
$1,170.79
Price history computed in-house
1W
-6.60%
1M
+1.52%
3M
+6.11%
1Y
+60.05%
YTD
+9.10%
SMA 50 $1,186.84 · below
SMA 200 $1,059.78 · above
52W position 81%
LLY overview
Related filings and maps
Public disclosures
Congress activity in LLY
No receipt-qualified Congressional disclosure is present for LLY in the cached public ledger.
Federal contracts
LLY contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LLY in this window.
Lobbying spend
LLY lobbying filings, year to date.
Registered lobbying filings matched to Eli Lilly and Co.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LLY in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for LLY.
Options
Sovereign unlock shows live options positioning for LLY.